Siemens Healthineers: Jefferies maintains Buy rating

(CercleFinance.com) - Jefferies confirms its 'buy' rating on Siemens Healthineers shares, along with its E60 target price, "With China set to re-accelerate in the course of FY24 and bright growth/margin prospects across most divisions".


Ahead of the publication of Q1 results, scheduled for 1 February, the broker says it expects organic growth of 4.5% and a margin of nearly 14.5% for the German group, with its EPS forecast below consensus.

"As per the company's guidance, the segments' performance in Q1 is likely to be at the lower end of the respective guidance ranges, mainly due to temporary headwinds from China", Jefferies explains.


Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.